

Efficiency and safety of generics (literature review)
https://doi.org/10.47470/0016-9900-2025-104-8-1075-1079
EDN: jljfzi
Abstract
In recent decades, the issue of using generics has become significant in the markets for pharmaceuticals, pesticides, and other industrial products. This review examines current approaches to assessing the effectiveness and safety of generics including pharmaceuticals and pesticides. The review is based on data from domestic and foreign literature, as well as online resources. Information was searched from the OECD, Scopus, Medline, and RSCI databases. The review presents and discusses the regulatory documents governing the assessment of the effectiveness and safety of generics. For generic drugs, pharmaceutical, biological, and therapeutic equivalence is evaluated. Technical-grade active ingredients of generic pesticides are not subjected to a full cycle of studies if their equivalence to the original active substance has been demonstrated. In such cases, the assessment includes the manufacturing process of the generic pesticide, the minimum content of the active substance, and the maximum allowable levels of impurities, supported by the analysis of at least five production batches. Additionally, an in silico hazard assessment of impurities is conducted. The genotoxicity of the technical-grade product and/or its impurities is also evaluated, and if necessary, toxicological, ecotoxicological, or other relevant data on the technical-grade product and/or its impurities are considered. The effectiveness of pesticides is assessed under the real-world (field) trials.
Contribution:
Ilyushina N.A. – concept and design of the study, processing and analysis of material, writing the text;
Egorova O.V. – processing and analysis of material;
Revazova Yu.A. – writing the text; processing and analysis of material.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.
Conflict of interest. The authors declare no conflict of interest.
Funding. The study is a part of the state assignment (registration № 125012700793-3).
Received: April 2, 2025 / Accepted: July 14, 2025 / Published: September 25, 2025
About the Authors
Nataliya A. IlyushinaRussian Federation
DSc (Biology), head, Department of genetic toxicology, Federal Scientific Center of Hygiene named after F.F. Erisman
Olga V. Egorova
Russian Federation
PhD (Biology), leading researcher of the Dept. of Genetic Toxicology of the Institute of Hygiene, Toxicology of Pesticides and Chemical Safety of the Federal Scientific Center of Hygiene named after F.F. Erisman, Mytishchi, 141014, Russian Federation
Yulia A. Revazova
Russian Federation
DSc (Biology), professor, Honoured Scientist of the Russian Federation, Chief researcher of the Department of genetic toxicology, Institute of Hygiene, Toxicology of Pesticides and Chemical Safety, Federal Scientific Center of Hygiene named after F.F. Erisman, Mytishchi, 141014, Russian Federation
References
1. Frohlich E.D. Generic drugs: the good, the bad, and the unknown. Ochsner J. 2011; 11(2): 98.
2. Shattuck A. Generic, growing, green?: The changing political economy of the global pesticide complex. J. Peasant Stud. 2021; 48(4): 1–23. https://doi.org/10.1080/03066150.2020.1839053
3. Stajszczak A., Majewski E. Importance of the generic segment of thye plant protection products – the case of the Polish market. APSTRACT Appl. Stud. Agribus. Commer. 2017; 11(1–2): 25–33. https://doi.org/10.19041/APSTRACT/2017/1-2/4
4. Class-specific rules for conducting studies of biosimilar medicinal products (bioanalogues). Appendix to the Rules for conducting studies of biosimilar medicinal products (bioanalogues). Moscow; 2014. (in Russian)
5. Khokhlov A.L., Pyatigorskaya N.V., eds. Preclinical Study of Medicinal Products (Industrial Pharmacy) [Doklinicheskoe izuchenie lekarstvennykh sredstv (promyshlennaya farmatsiya)]. Moscow; 2021. https://elibrary.ru/awltqg (in Russian)
6. Durnev A.D., Zhanatayev A.K., Eremina N.V. Genetic Toxicology [Geneticheskaya toksikologiya]. Moscow; 2022. https://elibrary.ru/fbwcbt (in Russian)
7. Guidelines for experimental (preclinical) study of new pharmacological substances. Moscow; 2000. (in Russian)
8. B&O Barristers. Features of registration of generic medicinal products (editorial article); 2020. (in Russian)
9. Khodzhaev N.S. Generics or original drugs? Rossiiskaya oftal’mologiya onlain N 3. Available at: https://eyepress.ru/article.aspx?9339 (in Russian)
10. Australian Government, Australian Pesticides and Veterinary Medicines Authority. Guideline for registering generic veterinary chemical products. Available at: https://apvma.gov.au/registrations-and-permits/data-guidelines/veterinary-data-guidelines/specific-guidelines/generic
11. WHO. International Code of Conduct on the Distribution and Use of Pesticides: Guidelines for the Registration of Pesticides; 2010.
12. European Food Safety Authority (EFSA). Pesticide evaluations: regulations and guidance; 2025. Available at: https://efsa.europa.eu/en/applications/pesticides/regulationsandguidance
13. OECD Guidelines for the Testing of Chemicals. Available at: https://www.oecd.org/en/topics/sub-issues/testing-of-chemicals/test-guidelines.html
14. WHO. Determination of equivalence for public health pesticides and pesticide products, report of a WHO consultation; 2017. Available at: https://apps.who.int/iris/bitstream/10665/251/1/WHO-HTM-NTD-WHOPES-2017.1-eng.pdf
15. Ilyushina N.A. Assessment of the equivalence of technical materials of analogous pesticides to original active substances on the basis of «mutagenicity» criterion. Ekologicheskaya genetika. 2019; 17(2): 101–12. https://doi.org/10.17816/ecogen172101-112 https://elibrary.ru/rdxvof (in Russian)
16. Damalas C.A., Eleftherohorinos I.G. Pesticide exposure, safety issues, and risk assessment indicators. Int. J. Environ. Res. Public Health. 2011; 8(5): 1402–19. https://doi.org/10.3390/ijerph8051402
17. Zhou W., Li M., Achal V. A comprehensive review on environmental and human health impacts of chemical pesticide usage. Emerg. Contam. 2025; 11(1): 100410. https://doi.org/10.1016/j.emcon.2024.100410
Review
For citations:
Ilyushina N.A., Egorova O.V., Revazova Yu.A. Efficiency and safety of generics (literature review). Hygiene and Sanitation. 2025;104(8):1075-1079. (In Russ.) https://doi.org/10.47470/0016-9900-2025-104-8-1075-1079. EDN: jljfzi